NCT03314402View on ClinicalTrials.gov

The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

August 30, 2018

Study Completion Date

September 27, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Jaktinib Dihydrochloride Monohydrate

Active Substance

DRUG

placebo

Placebo

Trial Locations (1)

Unknown

First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY

NCT03314402 - The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers | Biotech Hunter | Biotech Hunter